FDA approves Sanofi/Regeneron cholesterol drug with limits

The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a
Read more: http://ift.tt/1S01DLG